Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-11

Clinical Trial Update: Hypofractionated Radiation Therapy for Glioblastoma [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 hypofractionated radiation therapy study for glioblastoma. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN